informed consent was obtained from all participants or their parents (if age <16 years), before participation.
Investigations
Morning basal serum cortisol levels at 8 AM (expected value: male 5-22 mg/dL; female 5.2-21.7 mg/dL; sensitivity 0.25 mg/dL, serum ACTH levels (expected value: 17-58.2 pg/ mL; sensitivity 0.22 pg/mL), and serum IgE levels (positive expected value>190 IU/ml; sensitivity 25 IU/ml) were measured using the enzyme link immunosorbent assay (ELISA; Biomerica, CA, USAin the case and control groups.
Disease Severity
Clinical severity of the disease was evaluated by the scoring of atopic dermatitis (SCORAD) index and was graded as mild (SCORAD<25), moderate (SCORAD: 25-50), and severe (SCORAD >50) [18] .
Statistical Analysis
All statistical analyses were performed using SPSS 16.0 (SPSS Inc, Chicago, IL, USA). To assess the quantitative variables, student's t-test and Mann-Whitney U test were used for independent groups and categorical variable, as appropriated.
Spearman correlation test was used to assess the correlation between variables. P<0.05 was considered as statistically significant.
Results
This study included 31 patients with vitiligo and 31 healthy controls. Demographics and clinical data of patients and controls are summarized in Table 1 . Basal serum cortisol level was found to be higher than the reference range in one patient from the AD group (3.2%); however, none of the Topical corticosteroids are the most widely used and the mainstay of treatment for AD [12] , but there is increasing concern about their systemic side effects, especially adrenal suppression. There is some evidence that the percutaneous systemic absorption of topical steroids may occur after the prolonged use of these drugs and may lead to the suppression of hypothalamic-pituitary-adrenal axis (HPAA) [13, 14] ; however, in the majority of these studies, "basic" HPAA function (before application of topical steroids) remained unevaluated. In other words, in most of these studies, the HPAA function was compared with controls only "after" the application of topical steroids. Few studies have evaluated the basic HPAA function, especially in children; however, the results are conflicting [15] [16] [17] .
This study aimed to evaluate the basal serum cortisol, adrenocorticotropic hormone (ACTH), and IgE levels in patients with AD (without any age limitation) and their correlation with the disease severity. 
Patients and Methods

Patients
Discussion
In this case-control study, no significant difference was observed in the basal serum cortisol and ACTH levels in patients with AD and the control group. Interestingly, we found that the severity of AD (SCORAD index) correlated with serum IgE level, but not with the serum cortisol level.
The literature review reveals various studies with distinct research designs and methodologies and conflicting results (Table 3) . the pediatric AD group [22] . The results of this study were compatible with our findings, although it was performed only on pediatric patients.
We found a positive correlation between the total serum IgE values and disease severity, and our study is in correlation with the results of Choen et al. [23] .
In conclusion, in the present study no difference was observed in both basal cortisol levels and ACTH values between the AD and control groups. The basal cortisol levels were not correlated with the disease severity, whereas the serum IgE level was significantly higher in AD patients and correlated with the disease severity. To the best of our knowledge, this was the first case-control study that evaluated HPAA in AD patients without any age limitation. The limitation of our study was its sample size; thus, further studies with larger sample size are necessary to investigate the complex interaction of the neuroendocrine, metabolic, and immune systems and to explain the available conflicting results. in patients with severe AD [16] . Nevertheless, two years later, the authors of this article confessed that they had made a fatal flaw in the execution of their study, which led to wrong interpretation and incorrect conclusion [20] . Surprisingly, none of the recent studies has referred to this corrigendum.
Afsar et al. reported that none of the pediatric patients with AD had basal serum cortisol levels below the lower limit of the reference range, and no difference was observed in the basal cortisol values when they were compared with those of the control group. They also reported that the severity of AD did not correlate with the serum cortisol values in 
